Open AccessImpact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer
Author(s) -
Guanghui Gao,
Meng Qiao,
Hongcheng Liu,
Tao Jiang,
Fei Zhou,
Xuefei Li,
Chao Zhao,
Xiaoxia Chen,
Chunxia Su,
Shengxiang Ren
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.09.19
Subject(s) - medicine , hazard ratio , lung cancer , confidence interval , cochrane library , meta analysis , oncology , gastroenterology , randomized controlled trial , clinical trial , subgroup analysis , population , combination therapy , environmental health
To investigate the impact of different immune checkpoint inhibitors (ICI), programmed-death ligand 1 (PD-L1) expression and clinical characteristics on clinical outcome of ICI plus conventional treatment in advanced lung cancer patients.